Effect of a Cognitive Behavioral Stress Management Psychoeducation Program in Nursing Students (SYPP)

March 28, 2026 updated by: Uşak University

The Effect of a Cognitive-Behavioral Approach-Based Stress Management Psychoeducation Program on Depressive, Anxiety, and Stress Symptom Levels in Nursing Students

This study aimed to evaluate the effect of a cognitive-behavioral approach-based stress management psychoeducation program on the depression, anxiety, and stress levels of nursing students. The study was conducted with undergraduate nursing students studying at the Faculty of Health Sciences of a university. Students in the experimental group received a structured stress management psychoeducation program based on the cognitive-behavioral approach. The control group received no intervention. Data were collected three times using self-report questionnaires: before, after, and three months after the intervention.

Study Overview

Detailed Description

This study was conducted to examine the effectiveness of a Cognitive Behavioral Approach-Based Stress Management Psychoeducation Program in undergraduate nursing students. This research was carried out using a randomized controlled experimental design with pre-test-post-test-follow-up measurements.

The Stress Management Psychoeducation Program was developed based on the principles of cognitive behavioral therapy and focused on stress awareness, cognitive restructuring, coping strategies, problem-solving skills, leisure activities, breathing exercises, and relaxation techniques. The program was presented by the researcher in group sessions. Three separate groups were formed, each consisting of 15 people. The training program consisted of 7 sessions, each lasting approximately 90 minutes. Data were collected at three time points using the Depression Anxiety Stress Scale (DASS-21): before the intervention (pre-test), immediately after the intervention (post-test), and three months after the intervention (follow-up test).

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Uşak, Turkey (Türkiye)
        • Usak University, Faculty of Health Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria

  • Scoring between 10 and 29 on the Beck Depression Inventory (BDI) during the initial assessment
  • Being between 18 and 25 years of age
  • Not having received any prior psychiatric diagnosis or treatment
  • Not having received prior stress management training
  • Volunteering to participate in the study

Exclusion Criteria

  • Scoring outside the 10-29 range on the BDS
  • Being under 18 or over 25 years of age
  • Having a history of psychiatric diagnosis or treatment
  • Having received stress management training
  • Refusing to participate in the study
  • Not having attended more than three sessions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CBT-Based Stress Management Psychoeducation Program
Participants in this group received a group-based stress management psychoeducation program, designed to improve coping skills and reduce perceived stress levels, over seven sessions.
The intervention implemented consisted of a structured psycho-educational program based on the principles of cognitive behavioral therapy. The program was conducted in group sessions and aimed to improve stress coping skills and reduce levels of depression, anxiety, and stress.
No Intervention: Control Group
Participants in this arm did not receive the psychoeducation program during the study period and were placed on a wait-list.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Depression, Anxiety, and Stress Levels
Time Frame: Baseline (pre-intervention), immediately after the intervention, and 3-month follow-up

Changes in depression, anxiety, and stress levels were assessed using the Depression Anxiety Stress Scale-21 (DASS-21).

The items on the scale are designed to assess how individuals have felt in the past week, and participants are asked to read these statements and rate the frequency of negative emotions. This 21-item scale uses a 4-point Likert scale (0=never-3=always) and consists of 7 questions each measuring the dimensions of depression, anxiety, and stress. A score of 5 or higher on the depression subscale, 4 or higher on the anxiety subscale, and 8 or higher on the stress subscale indicates that the individual has the relevant problem.

Baseline (pre-intervention), immediately after the intervention, and 3-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Saliha Esra ERYILMAZ AYDIN, PhD, Usak University, Faculty of Health Sciences, Department of Nursing

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2022

Primary Completion (Actual)

May 15, 2022

Study Completion (Actual)

August 16, 2022

Study Registration Dates

First Submitted

February 26, 2026

First Submitted That Met QC Criteria

March 28, 2026

First Posted (Actual)

April 2, 2026

Study Record Updates

Last Update Posted (Actual)

April 2, 2026

Last Update Submitted That Met QC Criteria

March 28, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be made publicly available due to ethical restrictions, as the study involves sensitive psychological data and participant consent did not cover data sharing beyond the research team.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress Management

Clinical Trials on CBT-Based Stress Management Psychoeducation Program

Subscribe